Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Drug Formulations for Chagas Disease Treatment (Deadline: 30 April 2024)
- Hybrid Materials and Their Applications in the Pharmaceutical or Medical Field (Deadline: 1 May 2024)
- Polymer- and Lipid-Based Nanostructured Drug Delivery Systems for the Treatment of CNS Diseases: Recent Advances towards Clinical Application, 2nd Edition (Deadline: 10 May 2024)
- Novel Dry Powder Formulation and Delivery Systems (Deadline: 15 May 2024)
- Dry Powder Inhalers (Deadline: 20 May 2024)
- Multicomponent Solid Forms as Modifying Agents for Drugs with Solubility Problems (Deadline: 20 May 2024)
- Pharmaceutical Manufacturing Process of Inhaled Drugs (Deadline: 25 May 2024)
- HIV/AIDS Prevention Formulation Design and Optimization and Its Pharmacokinetic-Pharmacodynamic Evaluation (Deadline: 30 May 2024)
- Modeling, Simulation and Data Analysis of Pharmaceutical Manufacturing Processes (Deadline: 31 May 2024)
- Pharmaceutical Polymorphs and Cocrystals and Their In Vitro and In Vivo Evaluation (Deadline: 31 May 2024)
- Drug Polymorphism and Dosage Form Design, 2nd Edition (Deadline: 10 June 2024)
- Advance in Development of Patient-Centric Dosage Form, 3rd Edition (Deadline: 10 June 2024)
- Antimicrobial Resistance and Antimicrobial Activity of Bioactive Compounds in Drug Formulations (Deadline: 15 June 2024)
- Advances in Pickering-Emulsion-Based Drug Delivery Systems (Deadline: 20 June 2024)
- Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages (Deadline: 20 June 2024)
- Controlled Crystallization of Active Pharmaceutical Ingredients, 2nd Edition (Deadline: 20 June 2024)
- Pharmaceutical Solid Forms: From Crystal Structure to Formulation (Deadline: 30 June 2024)
- Antimicrobial Agents Based on Nanomaterials (Deadline: 30 June 2024)
- Formulation and Delivery of Traditional Medicines and Natural Products (Deadline: 30 June 2024)
- Recent Advances in Drugs and Prodrugs Design in the Field of Infectious Diseases (Deadline: 30 June 2024)
- Formulation of Poorly Water-Soluble Drugs (Deadline: 30 June 2024)
- Recent Advances in Oral Pharmaceutical Forms (Deadline: 30 June 2024)
- Advanced Pediatric Drug Formulation Strategies (Deadline: 30 June 2024)
- A Commemorative Issue in Honor of Professor Gregory Gregoriadis: Liposomes for the Delivery of Drugs and Vaccines (Deadline: 30 June 2024)
- Drug Repurposing and Delivery Systems for Immunotherapy (Deadline: 30 June 2024)
- Recent Progress in Solid Dispersion Technology, 3rd Edition (Deadline: 30 June 2024)
- Impact of Raw Material Properties on Solid Dosage Form Processes (Deadline: 5 July 2024)
- Recent Advances in Pharmaceutical Dosage Forms (Deadline: 20 July 2024)
- Advanced Spray Drying Technology in Pharmaceutical Formulations: Novel Applications Using Polymeric and Lipidic Excipients (Deadline: 20 July 2024)
- Essential Oils in Pharmaceutical Products (Volume II) (Deadline: 30 July 2024)
- Orally Disintegrating Dosage Forms Based on Cyclodextrins and Hydrophilic Polymers (Deadline: 31 July 2024)
- Advances in Natural Products for Cutaneous Application (Deadline: 15 August 2024)
- Oxidative Stress and Inflammation: Novel Drug Formulation and Delivery Systems (Deadline: 20 August 2024)
- Natural Product Pharmaceuticals (Deadline: 20 August 2024)
- Essential Oils for Pharmaceutical Applications (Deadline: 20 August 2024)
- Nanoparticle-Mediated Diagnostics and Drug Delivery Therapy (Deadline: 24 August 2024)
- Improving the Bioavailability and Solubility of Pharmaceutical Formulations (Deadline: 31 August 2024)
- Pharmaceutical Formulations with Antimicrobial Properties, 2nd Edition (Deadline: 10 September 2024)
- Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside, 2nd Edition (Deadline: 10 September 2024)
- New Trends in the Controlled Release Systems of Medicinal Substances Used in the Treatment of Diseases of the Central Nervous System (Deadline: 20 September 2024)
- Further Research in Polyphenols Formulations (Deadline: 30 September 2024)
- New Perspectives for the Administration of Cannabis for Medical Use: From Traditional to Advanced Formulations. What Next? (Deadline: 30 September 2024)
- Biofunctional Pharmaceutical Additives for Targeted, Improved Bioavailability and Safety of Medicine (Deadline: 30 September 2024)
- Formulation Design of Lipid Nanoparticles for Pharmaceutical Applications (Deadline: 10 October 2024)
- Ionic Liquids in Pharmaceutical and Biomedical Applications, 2nd Edition (Deadline: 30 October 2024)
- Establishment Tips and Development Strategies for Innovative Pharmaceutical Formulation Products (Deadline: 30 October 2024)
- Pharmaceutical Co-Crystals: Manufacturing, Bioavailability and Trends (Deadline: 30 October 2024)
- Exploring the Versatility of Cyclodextrins in Pharmaceutical Formulations (Deadline: 31 October 2024)
- Dosage Form Design for Oral Administration (Deadline: 31 October 2024)
- Customized Pharmaceutics: Innovations for Diverse Populations (Deadline: 31 October 2024)
- Innovative Formulations of Poorly Soluble Drugs (Deadline: 31 October 2024)
- Stability of Medicines and Novel Approaches for Predicting Drug Stability (Deadline: 10 November 2024)
- Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals (Deadline: 20 November 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
